EDITAS MEDICINE INC.
3.1550
07-November-24 11:36:53
15 minutes delayed
Stocks
-0.1250
-3.81%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
Editas Medicine Announces First Quarter 2022 Results and Business Updates
04 May 2022 06:45:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2022 Results and Corporate Update
27 Apr 2022 06:55:00 By Nasdaq GlobeNewswire
-
26 Apr 2022 09:00:03 By Nasdaq GlobeNewswire
-
Editas Medicine Appoints Gilmore O’Neill as Chief Executive Officer
14 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2022 09:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
-
28 Feb 2022 16:01:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates
24 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
16 Feb 2022 06:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
10 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 06:58:00 By Nasdaq GlobeNewswire
-
20 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2021 18:00:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Third Quarter 2021 Results and Business Updates
08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bernadette Connaughton to Board of Directors
28 Oct 2021 09:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
25 Oct 2021 16:01:00 By Nasdaq GlobeNewswire